Remimazolam in pediatric ambulatory anesthesia: a critical review and clinical perspective

Yi Zhang1, Hongchen Liu2, Linyun Wang3

  • 1Department of Anesthesiology, Maternal and Child Health Hospital of Wanzhou District, Chongqing, China.

Frontiers in Medicine
|December 31, 2025
PubMed

Insights

Remimazolam shows promise for pediatric anesthesia due to its rapid action and recovery. However, more research, especially in infants and on long-term effects, is needed before widespread use.

Area of Science:

  • Anesthesiology
  • Pediatric Pharmacology

Background:

  • Pediatric anesthesia requires agents with rapid onset, precise control, and predictable recovery.
  • Remimazolam, an ultrashort-acting benzodiazepine, theoretically fits these requirements due to its unique metabolism.

Purpose of the Study:

  • To evaluate the current evidence for remimazolam in pediatric day surgery.
  • To identify gaps in knowledge regarding its use in young children and long-term outcomes.

Main Methods:

  • Review of existing pediatric studies on remimazolam.
  • Analysis of limitations in current evidence, including study size and design.

Main Results:

  • Current pediatric evidence for remimazolam is limited, primarily from small observational studies.
  • Significant data gaps exist for infants under two years and for long-term neurodevelopmental effects.

Conclusions:

  • Remimazolam presents a potential option for pediatric anesthesia.
  • Cautious use in selected cases is advised pending robust randomized controlled trials and further safety data.

Related Concept Videos

Parenteral Anesthetics: Overview01:24

Parenteral Anesthetics: Overview

Intravenous anesthetics are drugs administered parenterally to induce anesthesia or sedation. Propofol is a widely used agent formulated as a 1% emulsion in soybean oil, glycerol, and egg phosphatide. It induces rapid anesthesia primarily due to its rapid distribution from the bloodstream to target tissues and is metabolized in the liver. However, it can cause significant pain on injection and hypertriglyceridemia. Fospropofol, a water-based prodrug of propofol, lacks these adverse effects.
540
Inhalational Anesthetics: Overview01:20

Inhalational Anesthetics: Overview

Inhalation anesthetics are drugs that induce general anesthesia upon inhalation. They work by increasing the sensitivity of GABAA receptors or inhibiting NMDA receptors, leading to a decrease in central nervous system activity. The depth of anesthesia can be rapidly adjusted by changing the concentration of the inhaled gas. Some common examples of inhalational anesthetics include volatile liquids like isoflurane, desflurane, sevoflurane and gases like xenon and nitrous oxide. Isoflurane, a...
937
General Anesthesia: Overview01:24

General Anesthesia: Overview

Anesthesia is a medical procedure that uses drugs for CNS suppression to enable painless surgeries and procedures. The selection of anesthetics is influenced by their pharmacokinetic properties, side effects, and patient characteristics. Various types of anesthesia include general, local, regional, spinal, and inhalational.
General anesthesia induces unconsciousness in the whole body, while the others target specific areas or sensations. It is administered to minimize adverse effects, maintain...
537
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
225
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
191